Optimized dosing for drug coated stents

A - Human Necessities – 61 – L

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61L 31/16 (2006.01)

Patent

CA 2458828

The inventors have found that both the drug dose and drug release profiles are significant factors for the safety and efficacy of drug coated stents. The inventors have identified optimum dosing and release kinetics for drug coated stents. In particular, the inventors have determined dosing and release kinetics that permit the delivery of the lowest effective drug dosage, thus enhancing patient safety and minimizing any side effects from the drug.

L'invention concerne des profils de dosage de médicaments et de libération de médicaments, se révélant être d'importants facteurs dans la sécurité et l'efficacité d'extenseurs enduits d'un médicament. L'invention a permis d'identifier un dosage optimal et une cinétique de libération pour les extenseurs enduits de médicaments. L'invention permet, en particulier, de déterminer un dosage et une cinétique de libération permettant d'administrer le plus faible dosage de médicament efficace, améliorant ainsi la sécurité du patient et minimisant les effets secondaires du médicament.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Optimized dosing for drug coated stents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Optimized dosing for drug coated stents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optimized dosing for drug coated stents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1795054

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.